News/Media Report-Pharmigene, Inc.

世基賺檢測財揪過敏基因 Pharmigene's revenue is increased due to the certified pharmacogenomic testings
2016-12-05

Pharmigene's revenue is increased this year due to those certified/licensed pharmacogenomic IVD products, with the boost of recently obtained KFDA approval and previous CFDA approval for HLA-B*1502/HLA-B*5801 kits.
世基基因檢測套組獲韓國上市許可 KFDA approval for HLA-B*5801 kit
2016-11-10

HLA-B*5801 testing obtained South Korea MFDS approval of class III medical devices. Phargmigene is going to provide kits for major medical centers and clinical laboratories in Korea from November.
基米併世基打開大陸商機 Pharmigene is acquired by Gnomics
2015-12-10

1 page / total 1

Pharmigene, Inc.